1. Market Research
  2. > Cancer Industry

Ovarian Cancer Industry, October 2016 Market Reports from Top Publishers

You might be interested in: Diagnostics, Therapy, Cancer, Antigen, Cancer Diagnostic, Immunotherapy, Surgery.


 
1-10 of 66 reports for Ovarian Cancer

Purchase Reports From Reputable Market Research Publishers

Molecular Diagnostics Market (By Application, Technology, Region and Companies) and Forecast to 2021 - Global Analysis

Molecular Diagnostics Market (By Application, Technology, Region and Companies) and Forecast to 2021 - Global Analysis

  • $ 1 100
  • Industry report
  • September 2016
  • by Igate Research

The molecular diagnostics market is one of the most rapidly growing segments of the in vitro diagnostics industry. Molecular diagnostics is a new class of diagnostic tests that identify molecular and genetic ...

Ovarian Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2016

Ovarian Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2016

  • $ 4 000
  • Industry report
  • September 2016
  • by Global Data

Ovarian Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2016 Summary GlobalData's Medical Devices sector report, “Ovarian Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, ...

Global Ovarian Cancer Partnering 2010 to 2016

Global Ovarian Cancer Partnering 2010 to 2016

  • $ 1 495
  • Industry report
  • September 2016
  • by Currentpartnering

The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and access to partnering deals and agreements entered into by the world’s leading healthcare companies. • ...

Ovarian Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

Ovarian Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

  • $ 2 000
  • Industry report
  • September 2016
  • by Delve Insight

SUMMARY DelveInsight’s Report, “Ovarian Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase ...

Metastatic Ovarian Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

Metastatic Ovarian Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

  • $ 2 000
  • Industry report
  • September 2016
  • by Delve Insight

SUMMARY DelveInsight’s Report, “Metastatic Ovarian Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, ...

Ovarian Cancer: Analytical Tool

Ovarian Cancer: Analytical Tool

  • $ 7 125
  • Industry report
  • August 2016
  • by Bioseeker

Analytical Tools are cancer area specific intelligence and surveillance toolkits within a select number of hot, emerging cancer therapy areas. They are designed to empower biotech/pharma professionals ...

Global Ovarian Cancer Drugs Market Report 2016

Global Ovarian Cancer Drugs Market Report 2016

  • $ 2 850
  • Industry report
  • August 2016
  • by 9Dimen Research

2016 Global Ovarian Cancer Drugs Report is a professional and in-depth research report on the world's major regional market conditions of the Ovarian Cancer Drugs industry, focusing on the main regions ...

Target Atlas in Ovarian Cancer: A Competitive Outlook

Target Atlas in Ovarian Cancer: A Competitive Outlook

  • $ 2 700
  • Industry report
  • August 2016
  • by Bioseeker

Extra value: One year of free online updates included with this product "Target Atlas in Ovarian Cancer: A Competitive Outlook" helps you to understand the complex world of commercial development in ovarian ...

Ovarian Cancer Drug Pathway Analyzer

Ovarian Cancer Drug Pathway Analyzer

  • $ 2 700
  • Industry report
  • August 2016
  • by Bioseeker

Extra value: One year of free online updates included with this product There are today at least 439 targeted molecular therapies known to affect more than 250 specific intracellular signaling pathways ...

Ovarian Cancer Drug Pipeline Update

Ovarian Cancer Drug Pipeline Update

  • $ 2 700
  • Company report
  • August 2016
  • by Bioseeker

With nearly 60,000 cases of ovarian cancer being diagnosed in the seven major markets each year, this cancer type is by no means small and therefore it remains an important secondary indication for existing ...

About 4 200 reports for Ovarian Cancer

Download Unlimited Documents from Trusted Public Sources

Cancer Statistics in the US

  • January 2015
    97 pages
  • Breast Cancer  

    Cancer  

    Ovarian Cancer  

  • United States  

View report >

Therapy Market In Canada

September 2016

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.